LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe. Moreover, it advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care.
Lung Cancer Europe provides a European platform for national lung cancer patient advocacy groups and supports the establishment of those groups in countries where such groups do not yet exist. Our member organisations and associate members come from all over Europe.
Lung cancer is literally the biggest cancer killer worldwide – causing more deaths than breast and prostate cancer put together all over the world. Read more about our diagnosis, types and stages of lung cancer, treatments and clinical trials, but also how to cope with lung cancer.
Lung Cancer Europe (LuCE) is holding a webinar on the role of the European Medicines Agency (EMA) and how patients and patient advocates can be involved in the drug approval process. The webinar is intended for an audience of advocates, patients and caregivers. It will be given by Kate Morgan, Head of Policy and Access of Myeloma Patients Europe (MPE). […]
Lung cancer is responsible for nearly 1 in 5 cancer related deaths in Europe, yet it remains a cancer that is underfunded and underrepresented. Previous research has demonstrated that many people impacted by lung cancer face disparities in access to diagnostics, treatment and care.
To mark World Cancer Day, LuCE has released its latest position paper which identifies disparities and challenges in access to lung cancer diagnostics and treatment across Europe. Data were collected through 34 healthcare professionals/researchers, 16 pharmaceutical companies and LuCE members (patient organizations).
We have published two webinars from the autumn of 2019 that might be of interest, Lung cancer screening – Basic concepts and implementation, and Diagnosis and treatment of lung cancer. Several more webinars are available her: https://www.lungcancereurope.eu/category/what-we-do/webinars/
Lung cancer is a complex disease that can have various causes. In this booklet, you will find a lot of information if you or someone you care for has been diagnosed with ALK+ lung cancer. An ALK+ diagnosis may affect you and your family in many ways. You may all need time and space to think about how ALK+ lung cancer […]
